Lysosomal compromise and brain dysfunction: Examining the role of neuroaxonal dystrophy

Steven U. Walkley, Jakub Sikora, Matthew Micsenyi, Cristin Davidson, Kostantin Dobrenis

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Lysosomal diseases are a family of over 50 disorders caused by defects in proteins critical for normal function of the endosomal/lysosomal system and characterized by complex pathogenic cascades involving progressive dysfunction of many organ systems, most notably the brain. Evidence suggests that compromise in lysosomal function is highly varied and leads to changes in multiple substrate processing and endosomal signalling, in calcium homoeostasis and endoplasmic reticulum stress, and in autophagocytosis and proteasome function. Neurons are highly vulnerable and show abnormalities in perikarya, dendrites and axons, often in ways seemingly unrelated to the primary lysosomal defect. A notable example is NAD (neuroaxonal dystrophy), which is characterized by formation of focal enlargements (spheroids) containing diverse organelles and other components consistent with compromise of retrograde axonal transport. Although neurons may be universally susceptible to NAD, GABAergic neurons, particularly Purkinje cells, appear most vulnerable and ataxia and related features of cerebellar dysfunction are a common outcome. As NAD is found early in disease and thus may be a contributor to Purkinje cell dysfunction and death, understanding its link to lysosomal compromise could lead to therapies designed to prevent its occurrence and thereby ameliorate cerebellar dysfunction.

Original languageEnglish (US)
Pages (from-to)1436-1441
Number of pages6
JournalBiochemical Society Transactions
Volume38
Issue number6
DOIs
StatePublished - Dec 2010

Fingerprint

Neuroaxonal Dystrophies
Neurons
Cerebellar Diseases
Brain
Purkinje Cells
GABAergic Neurons
Defects
Axonal Transport
Endoplasmic Reticulum Stress
Calcium Signaling
Autophagy
Proteasome Endopeptidase Complex
Ataxia
Dendrites
Organelles
Axons
Homeostasis
Cell Death
Calcium
Substrates

Keywords

  • Autophagy
  • Axonal spheroid
  • Axoplasmic transport
  • Lysosomal disease
  • Niemann-Pick type C disease
  • Purkinje cell

ASJC Scopus subject areas

  • Biochemistry

Cite this

Lysosomal compromise and brain dysfunction : Examining the role of neuroaxonal dystrophy. / Walkley, Steven U.; Sikora, Jakub; Micsenyi, Matthew; Davidson, Cristin; Dobrenis, Kostantin.

In: Biochemical Society Transactions, Vol. 38, No. 6, 12.2010, p. 1436-1441.

Research output: Contribution to journalArticle

@article{6ae53f65cf06475a85409f8812073406,
title = "Lysosomal compromise and brain dysfunction: Examining the role of neuroaxonal dystrophy",
abstract = "Lysosomal diseases are a family of over 50 disorders caused by defects in proteins critical for normal function of the endosomal/lysosomal system and characterized by complex pathogenic cascades involving progressive dysfunction of many organ systems, most notably the brain. Evidence suggests that compromise in lysosomal function is highly varied and leads to changes in multiple substrate processing and endosomal signalling, in calcium homoeostasis and endoplasmic reticulum stress, and in autophagocytosis and proteasome function. Neurons are highly vulnerable and show abnormalities in perikarya, dendrites and axons, often in ways seemingly unrelated to the primary lysosomal defect. A notable example is NAD (neuroaxonal dystrophy), which is characterized by formation of focal enlargements (spheroids) containing diverse organelles and other components consistent with compromise of retrograde axonal transport. Although neurons may be universally susceptible to NAD, GABAergic neurons, particularly Purkinje cells, appear most vulnerable and ataxia and related features of cerebellar dysfunction are a common outcome. As NAD is found early in disease and thus may be a contributor to Purkinje cell dysfunction and death, understanding its link to lysosomal compromise could lead to therapies designed to prevent its occurrence and thereby ameliorate cerebellar dysfunction.",
keywords = "Autophagy, Axonal spheroid, Axoplasmic transport, Lysosomal disease, Niemann-Pick type C disease, Purkinje cell",
author = "Walkley, {Steven U.} and Jakub Sikora and Matthew Micsenyi and Cristin Davidson and Kostantin Dobrenis",
year = "2010",
month = "12",
doi = "10.1042/BST0381436",
language = "English (US)",
volume = "38",
pages = "1436--1441",
journal = "Biochemical Society Transactions",
issn = "0300-5127",
publisher = "Portland Press Ltd.",
number = "6",

}

TY - JOUR

T1 - Lysosomal compromise and brain dysfunction

T2 - Examining the role of neuroaxonal dystrophy

AU - Walkley, Steven U.

AU - Sikora, Jakub

AU - Micsenyi, Matthew

AU - Davidson, Cristin

AU - Dobrenis, Kostantin

PY - 2010/12

Y1 - 2010/12

N2 - Lysosomal diseases are a family of over 50 disorders caused by defects in proteins critical for normal function of the endosomal/lysosomal system and characterized by complex pathogenic cascades involving progressive dysfunction of many organ systems, most notably the brain. Evidence suggests that compromise in lysosomal function is highly varied and leads to changes in multiple substrate processing and endosomal signalling, in calcium homoeostasis and endoplasmic reticulum stress, and in autophagocytosis and proteasome function. Neurons are highly vulnerable and show abnormalities in perikarya, dendrites and axons, often in ways seemingly unrelated to the primary lysosomal defect. A notable example is NAD (neuroaxonal dystrophy), which is characterized by formation of focal enlargements (spheroids) containing diverse organelles and other components consistent with compromise of retrograde axonal transport. Although neurons may be universally susceptible to NAD, GABAergic neurons, particularly Purkinje cells, appear most vulnerable and ataxia and related features of cerebellar dysfunction are a common outcome. As NAD is found early in disease and thus may be a contributor to Purkinje cell dysfunction and death, understanding its link to lysosomal compromise could lead to therapies designed to prevent its occurrence and thereby ameliorate cerebellar dysfunction.

AB - Lysosomal diseases are a family of over 50 disorders caused by defects in proteins critical for normal function of the endosomal/lysosomal system and characterized by complex pathogenic cascades involving progressive dysfunction of many organ systems, most notably the brain. Evidence suggests that compromise in lysosomal function is highly varied and leads to changes in multiple substrate processing and endosomal signalling, in calcium homoeostasis and endoplasmic reticulum stress, and in autophagocytosis and proteasome function. Neurons are highly vulnerable and show abnormalities in perikarya, dendrites and axons, often in ways seemingly unrelated to the primary lysosomal defect. A notable example is NAD (neuroaxonal dystrophy), which is characterized by formation of focal enlargements (spheroids) containing diverse organelles and other components consistent with compromise of retrograde axonal transport. Although neurons may be universally susceptible to NAD, GABAergic neurons, particularly Purkinje cells, appear most vulnerable and ataxia and related features of cerebellar dysfunction are a common outcome. As NAD is found early in disease and thus may be a contributor to Purkinje cell dysfunction and death, understanding its link to lysosomal compromise could lead to therapies designed to prevent its occurrence and thereby ameliorate cerebellar dysfunction.

KW - Autophagy

KW - Axonal spheroid

KW - Axoplasmic transport

KW - Lysosomal disease

KW - Niemann-Pick type C disease

KW - Purkinje cell

UR - http://www.scopus.com/inward/record.url?scp=78649752501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649752501&partnerID=8YFLogxK

U2 - 10.1042/BST0381436

DO - 10.1042/BST0381436

M3 - Article

C2 - 21118103

AN - SCOPUS:78649752501

VL - 38

SP - 1436

EP - 1441

JO - Biochemical Society Transactions

JF - Biochemical Society Transactions

SN - 0300-5127

IS - 6

ER -